Brief: Adaptive Biotechnologies Q2 EPS USD -0.25
29/07/2026 21:06
Jul 29 (Reuters) - Adaptive Biotechnologies Q2 revenue USD 71.553 million vs. IBES estimate USD 65.9 million. * Q2 operating expenses USD 87.323 million * Q2 net income USD -39.941 million * Q2 operating income USD -15.77 million * Q2 adjusted EBITDA USD -700 thousand
Recent news on Adaptive Biotechnologies
See all newsAdvisory: Alert incorrectly tagged to Adaptive Biotechnologies withdrawn
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Adaptive Biotechnologies Corp reports results for the quarter ended June 30 - Earnings Summary
Adaptive Biotechnologies Q2 revenue rises 22%, beats estimates